KR910011850A - 4-치환 카르보닐 쿠마린 화합물 - Google Patents

4-치환 카르보닐 쿠마린 화합물

Info

Publication number
KR910011850A
KR910011850A KR1019900022129A KR900022129A KR910011850A KR 910011850 A KR910011850 A KR 910011850A KR 1019900022129 A KR1019900022129 A KR 1019900022129A KR 900022129 A KR900022129 A KR 900022129A KR 910011850 A KR910011850 A KR 910011850A
Authority
KR
South Korea
Prior art keywords
group
substituted
hydrogen atom
carbonylcoumarin
compound
Prior art date
Application number
KR1019900022129A
Other languages
English (en)
Other versions
KR920010073B1 (ko
Inventor
츠카사 오야마
카즈히코 무라야마
요리아키 마츠자키
스스무 가사마츠
케이스케 다쿠마
기미토시 가토
Original Assignee
사와무라 하루오
미쓰이 도오마쓰 가가쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사와무라 하루오, 미쓰이 도오마쓰 가가쿠 가부시키가이샤 filed Critical 사와무라 하루오
Publication of KR910011850A publication Critical patent/KR910011850A/ko
Application granted granted Critical
Publication of KR920010073B1 publication Critical patent/KR920010073B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004—Photosensitive materials
    • G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/028—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
    • G03F7/031—Organic compounds not covered by group G03F7/029

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

내용 없음.

Description

4-치환 카르보닐 쿠마린 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
도면은, 실시예에서 얻어진 본 화합물의 IR흡수 스펙트럼을 나타낸다.
제1도는 실시예 1에서 합성한 3-(벤조티아조-2-일)-4-에톡시카르보닐-7-디에틸아미노쿠마린의 IR흡수 스펙트럼이다.

Claims (7)

  1. 하기 일반식(Ⅰ)로 표시되는 4-치환 카르보닐쿠마린 화합물
    상기식에서, R1,R2는 각각 같거나 또는 독립으로 수소원자, 알킬기, 알콕시알킬기, 알케닐기, 히드록시알킬기, 아르알킬기, 아릴기, 알콕시카르보닐알킬기를 나타내며, 상호 결합하거나, 골격내의 아미노기가 치환된 벤젠핵과 결합하여 환을 형성하여도 좋고, R3는 수소원자, 알킬기, 알콕시알킬기, 히드록시알킬기, 할로게노알킬기, 수산기, 알콕시기, 알콕시알콕시기, 알콕시카르보닐기, 술폰산기, 할로겐 원자를 나타내고, X는 수소원자 알킬기, 시크로알킬기, 알콕시기, 시크로알콕시기, 수산기, 아릴기, 알케닐기, 아릴옥시기, 알케닐옥시기, 아르알킬기, 아르알킬옥시기, 알콕시카르보닐알콕시기, 알킬카르보닐알콕시기, 또는 다음의 치환기를 나타낸다.
    (여기에서 R4, R5는 수소원자, 알킬기, 히드록시알킬기, 히드록시알콕시알킬기, 알콕시알킬기, 시크로알킬기를 나타내고, n, m은 각각 1-5의 정수이다) 또한 Y는 수소원자, 알킬카르보닐기, 알콕시카르보닐기, 아릴기, 아릴카르보닐기, 알릴옥시카르보닐기, 알콕시카르보닐 알킬카르보닐기, 알콕시카르보닐알콕시카르보닐기 또는 헤테로 환기를 나타낸다.
  2. 제1항에 있어서, X가 알콕시기, 시크로알콕시기, 수산기, 아릴기, 아릴옥시기, 알콕시옥시기, 아르알킬옥시기, 알콕시카르보닐알콕시기, 알킬카르보닐알콕시기와 구조식로 된 치환체로부터 선택됨을 특징으로 하는 4-치환 카르보닐쿠마린 화합물.
  3. 제1항에 있어서, X는 알콕시기, 시크로알콕시기, 수산기, 아릴기, 아릴옥시기, 알케닐옥시기, 아르알킬옥시기, 알콕시카르보닐알콕시기, 알킬카르보닐알콕시기와 구조식로 된 치환체로부터 선택되고 Y는 알킬카르보닐기이거나 헤테로사이클릭환임을 특징으로 하는 4-치환카르보닐 쿠마린 화합물.
  4. 제3항에 있어서, 헤테로사이클릭환은
    로부터 선택됨을 특징으로 하는 4-치환카르보닐쿠마린 화합물.
  5. 제2항에 있어서, 일반식(Ⅰ)에서 R1과 R2는 에틸, R3는 수소원자임을 특징으로 하는 4-치환카르보닐쿠마린 화합물.
  6. 제3항에 있어서, 일반식(Ⅰ)에서 R1과 R2는 에틸, R3는 수소원자임을 특징으로 하는 4-치환카르보닐쿠마린 화합물.
  7. 제4항에 있어서, 일반식(Ⅰ)에서 R1과 R2는 에틸, R3는 수소원자임을 특징으로 하는 4-치환카르보닐쿠마린 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900022129A 1989-12-28 1990-12-28 4-치환 카르보닐 쿠마린 화합물 KR920010073B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33828289 1989-12-28
JP1-338282 1989-12-28
JP338282 1989-12-28

Publications (2)

Publication Number Publication Date
KR910011850A true KR910011850A (ko) 1991-08-07
KR920010073B1 KR920010073B1 (ko) 1992-11-13

Family

ID=18316657

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900022129A KR920010073B1 (ko) 1989-12-28 1990-12-28 4-치환 카르보닐 쿠마린 화합물

Country Status (4)

Country Link
EP (1) EP0435261B1 (ko)
KR (1) KR920010073B1 (ko)
CA (1) CA2032602C (ko)
DE (1) DE69025733T2 (ko)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547579A (en) * 1978-10-10 1985-10-15 Ciba-Geigy Corporation Substituted benzopyran compounds
DE3329394A1 (de) * 1983-08-13 1985-02-28 Bayer Ag, 5090 Leverkusen Chromogene und fluorogene carbonsaeureester, verfahren zu deren herstellung sowie verfahren und mittel zum nachweis und zur bestimmung von hydrolasen
SE8505716D0 (sv) * 1985-12-03 1985-12-03 Biocarb Ab Novel compounds and conjugates thereof

Also Published As

Publication number Publication date
DE69025733D1 (de) 1996-04-11
CA2032602C (en) 2001-12-25
DE69025733T2 (de) 1996-09-19
EP0435261A3 (en) 1991-12-11
CA2032602A1 (en) 1991-06-29
EP0435261B1 (en) 1996-03-06
KR920010073B1 (ko) 1992-11-13
EP0435261A2 (en) 1991-07-03

Similar Documents

Publication Publication Date Title
KR890005084A (ko) 퀴놀린 유도체
KR920002707A (ko) 음이온 화합물
KR960704919A (ko) 신규인 펩티드 유도체 (novel peptide derivative)
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
KR860001104A (ko) 테트라히드로프탈이미드의 제조방법
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
KR840006327A (ko) 페닐에틸아민 유도체의 제조방법
BG96285A (bg) 1-арил-5-/субституирани алкилиденимино/пиразоли с пестицидна активност
ATE34976T1 (de) Arylcyclobutylalkylamine und ihre verwendung als antidepressive arzneimittel.
ES8500258A1 (es) Un procedimiento para la preparacion de una 4-hidroxi-cumarina substituida con tetralilo
KR900004714A (ko) 신규의 3,4-디아미노 퀴놀린 및 피리딘계 화합물
GB1501935A (en) 5-nitropyrimidine derivatives and their use for influencing plant growth
KR840007406A (ko) 중추 신경계에 활성을 나타내는 복소환 화합물의 제조방법
DE69617909D1 (de) 2-substituierte vitamin-d3-derivate
KR890014536A (ko) 축합 퀴놀린계 화합물, 축합 아크리딘계 화합물 및 그의 제조방법과 그것을 함유하는 항암제 조성물
KR960010644A (ko) 캠프토테신, 그 제조방법 및 항 종양제
KR840006207A (ko) 6-치환된-퀴놀린-5,6-퀴논의 제조방법
KR910011850A (ko) 4-치환 카르보닐 쿠마린 화합물
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
CA2188924A1 (en) Arylpiperidine and arylpiperazine derivatives and drugs containing the same
KR870004038A (ko) 제초제 화합물의 제조방법
KR890016006A (ko) 피롤 유도체
KR870003074A (ko) 피라졸 유도체의 제조방법
KR850000034A (ko) 테트라하이드로-β-카르보린 유도체의 제조방법
KR830006293A (ko) 신규 폴리아자 헤테로고리 화합물의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20051111

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee